RITSUKO KOMAKI to Patient Compliance
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Patient Compliance.
Connection Strength
0.069
-
Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324. J Clin Oncol. 2011 Jun 10; 29(17):2312-8.
Score: 0.069